MITOXANTRONE AS 1ST LINE CYTO-TOXIC THERAPY IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS OF A PHASE-II STUDY

被引：19

作者：

MOURIDSEN, HT ^{[1
]}

ROSE, C ^{[1
]}

NOOY, MA ^{[1
]}

VANOOSTEROM, AT ^{[1
]}

机构：

[1] ACAD ZIEKENHUIS LEIDEN,DEPT CLIN ONCOL,LEIDEN,NETHERLANDS

来源：

关键词：

D O I：

10.1016/0305-7372(83)90022-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：47 / 52

页数：6

共 12 条

[1]

[Anonymous], 1979, WHO HDB REPORTING RE

CHENG, CC ;

ZBINDEN, G ;

ZEECHENG, RKY .

[3]

DIMARCO A, 1976, CANCER RES, V36, P1962

[4]

HAYWARD JL, 1977, CANCER, V39, P1289, DOI 10.1002/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO

[5]

2-F

[6]

HENDERSON BM, 1982, CANCER TREAT REP, V66, P1139

[7]

HOOGSTRATEN B, 1976, CANCER, V38, P13, DOI 10.1002/1097-0142(197607)38:1<13::AID-CNCR2820380104>3.0.CO

[8]

2-5

[9]

SMITH IE, 1983, CANCER TREAT REV, V10, P103, DOI 10.1016/0305-7372(83)90008-7

[10]

STUARTHARRIS RC, 1982, CANCER CHEMOTH PHARM, V8, P179